Loading insider details...
Latest Form 4 (Jun 18, 2026): Grant/Award of 57,100 ZNTL shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 18, 2026 | Zentalis Pharmaceuticals, Inc. (ZNTL) | Grant/Award | 57,100 | n/a |
| Jun 12, 2026 | Monte Rosa Therapeutics, Inc. (GLUE) | Grant/Award | 25,800 | n/a |
| Jun 18, 2025 | Zentalis Pharmaceuticals, Inc. (ZNTL) | Grant/Award | 57,603 | n/a |
| Jun 16, 2025 | Monte Rosa Therapeutics, Inc. (GLUE) | Grant/Award | 30,700 | n/a |
| Feb 4, 2025 | Zentalis Pharmaceuticals, Inc. (ZNTL) | Purchase | 60,000 | $103.4K |
| Jun 21, 2024 | Zentalis Pharmaceuticals, Inc. (ZNTL) | Grant/Award | 41,581 | n/a |
| Jun 13, 2024 | Monte Rosa Therapeutics, Inc. (GLUE) | Grant/Award | 22,100 | n/a |
| Sep 13, 2023 | Zentalis Pharmaceuticals, Inc. (ZNTL) | Sale | 5,000 | $125.2K |
| Jun 16, 2023 | Zentalis Pharmaceuticals, Inc. (ZNTL) | Grant/Award | 16,364 | n/a |
| Jun 15, 2023 | Monte Rosa Therapeutics, Inc. (GLUE) | Grant/Award | 20,500 | n/a |